glp-1 masld Resmetirom and agonists for MASH: complementary rather than exclusive Glucagon-like Peptide-1 Receptor Agonists (GLP-1

Identifying patient subgroups that are most likely to benefit from GLP-1RAs based on these factors could improve treatment outcomes and minimize side effects

The first GLP-1 medication received approval from the United States Food and Drug Administration in 2005

Retatrutide dosing schedule Retatrutide is a once-weekly injection

How GLP-1 medications work GLP-1s are FDA-approved type 2 diabetes and weight-loss medications that mimic a naturally occurring gut hormone (or, in some cases, two gut hormones) your body produces when you eat

Some patients may require more aggressive dosing while others may be quite sensitive and opt to remain at lower doses

Crucially, this action is glucose-dependent, meaning it primarily happens when blood sugar levels are high, such as after a meal